Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-09

FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved Bayer’s supplemental application for Claritin-D 24 Hour, adding a 24-hour loratadine and pseudoephedrine sulfate formulation. The product is intend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLARITIN-D 24 HOUR (loratadine and pseudoephedrine sulfate)

Snippet

SUPPL AP for CLARITIN-D 24 HOUR (LORATADINE AND PSEUDOEPHEDRINE SULFATE)